CNSP
CNS Pharmaceuticals, Inc. Common Stock
stockNASDAQ
At CloseOct 19, 2026
4.99USD+2.865%(+0.14)346
CNSP Financials
In Q2 FY 2026 (ended ), CNS Pharmaceuticals, Inc. Common Stock (CNSP) reported net income of −$2.59M, operating cash flow of −$3.54M, and assets of $21.94M.
Loading financial statements…